黑色素瘤,恶性的临床试验
总计7171个结果
-
The Netherlands Cancer InstituteCopenhagen University Hospital at Herlev主动,不招人
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLC终止
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; National Cancer Institute (NCI); Medarex完全的
-
Iovance Biotherapeutics, Inc.主动,不招人
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI); NCIC Clinical Trials Group; Children's Oncology Group; Cancer and... 和其他合作者主动,不招人
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; SWOG Cancer Research Network完全的
-
Novartis Pharmaceuticals终止
-
F. Stephen Hodi, MDMedImmune LLC完全的
-
The Christie NHS Foundation TrustNational Institute for Health Research, United Kingdom终止
-
Biocad主动,不招人黑色素瘤 | 黑色素瘤转移俄罗斯联邦, 白俄罗斯
-
Netherlands Working Group on Immunotherapy of OncologyHoffmann-La Roche; Amsterdam UMC, location VUmc; The Netherlands Cancer Institute终止
-
Bristol-Myers Squibb完全的
-
Nektar TherapeuticsImaginAb, Inc.撤销
-
OncoImmune, Inc.National Cancer Institute (NCI); Huntsman Cancer Institute撤销
-
Craig L Slingluff, JrNational Cancer Institute (NCI)完全的
-
BioNTech US Inc.Apexigen, Inc.终止
-
Craig L Slingluff, JrNational Cancer Institute (NCI)完全的
-
Nantes University HospitalUMR892完全的
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics Inc.完全的
-
Osaka UniversityMerck Sharp & Dohme LLC; ISHIHARA SANGYO KAISHA,LTD. Japan未知
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Melanoma Research Foundation Breakthrough ConsortiumGenentech, Inc.终止
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)完全的
-
University Hospital, Caen完全的
-
Istituto Oncologico Veneto IRCCSJanssen Diagnostics, LLC未知
-
National Center for Tumor Diseases, HeidelbergUniversity Hospital Heidelberg完全的
-
Hoag Memorial Hospital Presbyterian完全的
-
Centre Oscar LambretNovartis; National Cancer Institute, France终止